Cargando…
Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan
The prognostic role of modified Glasgow Prognostic Score (mGPS), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with salivary duct carcinoma (SDC) remains unclear. We conducted a multi-institutional retrospective cohort study of 140 SDC patients. The survival...
Autores principales: | Kawakita, Daisuke, Tada, Yuichiro, Imanishi, Yorihisa, Beppu, Shintaro, Tsukahara, Kiyoaki, Kano, Satoshi, Ozawa, Hiroyuki, Okami, Kenji, Sato, Yuichiro, Shimizu, Akira, Sato, Yukiko, Fushimi, Chihiro, Takase, Soichiro, Okada, Takuro, Sato, Hiroki, Otsuka, Kuninori, Watanabe, Yoshihiro, Sakai, Akihiro, Ebisumoto, Koji, Togashi, Takafumi, Ueki, Yushi, Ota, Hisayuki, Shimura, Tomotaka, Hanazawa, Toyoyuki, Murakami, Shingo, Nagao, Toshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352036/ https://www.ncbi.nlm.nih.gov/pubmed/27894101 http://dx.doi.org/10.18632/oncotarget.13565 |
Ejemplares similares
-
Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification
por: Takase, Soichiro, et al.
Publicado: (2017) -
Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas
por: Shimura, Tomotaka, et al.
Publicado: (2017) -
The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma
por: Hirai, Hideaki, et al.
Publicado: (2020) -
Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients
por: Otsuka, Kuninori, et al.
Publicado: (2016) -
The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy
por: Saigusa, Natsuki, et al.
Publicado: (2022)